Publication | Open Access

Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative

Breast OncologyOncologyOverall SurvivalBreast CancerCancer TreatmentMedicineRadiation OncologyRadiologyHealth Sciences